Bulletin of Environment, Pharmacology and Life Sciences [BEPLS] is a monthly peer reviewed open access international journal focused towards the rapid publication of fundamental research papers on all areas of Environment, Pharmacology and Life Sciences. BEPLS is official publication of Academy for Environment and Life Sciences [Regd. Under Societies Registration Act XXI, 1860]. BEPLS is a monthly published online Journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Life Sciences i.e. Zoology, Botany, Ecology, Cell Biology, Immunology, Environmental Sciences, Toxicology, Aquaculture, Microbiology, Biotechnology, Bioinformatics, Medical Sciences, Genetics, Biodiversity and Conservation, Taxonomy, Veterinary Sciences, Pharmaceutics, Pharmacology, Molecular Biology, Behavioral Biology, Fisheries, Conservation Biology, Evolutionary Biology, Limnology, Environmental Impact Assessment, Agricultural, Pest Management, Apiculture, Sericulture, Wild Life, Novel Drug Delivery, Biopharmaceutics, Pharmacognosy, Pharmaceutical Analysis, Food and Nutrition And Genomics. All manuscripts are subject to rapid peer review. Those of high quality () will be published without delay.
The aim of BEPLS is to serve a comprehensive platform to promote advances in life sciences across a wide spectrum of scientific disciplines.
Authors are expected to adhere to the highest standard with respect to publication ethics, any cases of ethical misconduct are treated very seriously. The acceptance criteria for all papers are the quality, originality of the research work, validity of data, reproducibility of results and papers that demonstrate new findings of relevance to the field as a whole and its significance to our readership will be considered and accepted for publication. BEPLS accepts submitted papers on the condition that they have been submitted only to BEPLS, that they have not been published already and is not under consideration for publication or in press elsewhere.
All the authors must have agreed to the submission of the final version of the manuscript, the order of their names on the title page and that the contributions of all people involved in the research have been properly acknowledged. They also must have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. To avoid any possible dispute during the process, changes to authorship (including the order of author's names, addition or deletion of the name) after submission or acceptance, should be accompanied by signed statements of agreement from all the authors involved as per the Committee on Publication Ethics (COPE) guidelines only.
Ethical Considerations; Compliance with Ethical Standards
Bulletin of Environment, Pharmacology and Life Sciences (BEPLS) follows a strict Publication Ethics and Malpractice Policy; Authors are expected to adhere to the highest standard with respect to publication ethics. The author(s) should declare that all text, data, figures/tables or other illustrations presented in the manuscript are completely original and does not contain or include material taken from other copyrighted sources and wherever such material has been included, proper citation is included in the reference section and also affirm that the work does not violate any proprietary or personal rights of others. Any cases of ethical misconduct are treated very seriously.
Authors should include the following statements (if applicable) in a separate section entitled "Compliance with Ethical Standards" when submitting a paper:
· Conflict of Interest Disclosure
· Ethics of Human and Animal Experimentation
· Informed Consent
Conflict of Interest Disclosure
At the time of submission, authors must include a disclosure statement in the body of the manuscript. All authors must declare any conflict of interest or any affiliation or involvement in any organization whether it is academic, commercial, financial, personal and professionally relevant to the work under consideration to avoid the potential for bias and accept responsibility for what is said in the manuscript.
Ethics of Human and Animal Experimentation Human Subject Research
The Author should ensure that studies involving experiments on humans must have an institutional review board (IRB) and/or national research ethics committee approval. Manuscripts should include a statement that the informed consent was obtained for experimentation with human subjects and that it conforms to standards currently applied in the country of origin. The name of the authorizing body should be stated in the paper. The privacy rights of human subjects must always be observed.
The Author should ensure that studies involving experiments on animals must include a statement in the manuscript indicating that the international, national, and/or institutional guidelines for the care and use of animals have been followed, and that the study has been approved by a research ethics committee. Procedures should be such that experimental animals do not have to suffer unnecessarily. Papers should include details of the procedures and of anaesthetics used.
All individuals have individual rights that are not to be infringed. Individual participants in studies have the right to decide what happens to the identifiable data gathered from them during a study. Hence it is important that all participants gave their informed consent in writing prior to inclusion in the study. The manuscripts that include information about participants, written informed consent for the publication of these must be obtained from all the participants.
Plagiarism Prevention Policy
Bulletin of Environment, Pharmacology and Life Sciences (BEPLS) follows a strong plagiarism policy and is committed to protecting the integrity of the scholarly record and feels its duty to help and support the scientific community in all aspects of research and publishing ethics.
BEPLS is a participant of Advanced Plagiarism Detection Software (Turnitin/ Quetext) to screen published and submitted content for originality.
By submitting articles to the Bulletin of Environment, Pharmacology and Life Sciences (BEPLS) the author(s) attest the following:
· All author of the article has thoroughly checked and approved the content of the article before submission
· No part of the manuscript is plagiarized from other sources
· Proper reference is provided wherever contents extracted from other sources
· If plagiarism is found strong action will be taken
All the papers submitted have to pass through an initial screening and will be checked through the Advanced Plagiarism Detection Software (Turnitin/ Quetext).
All article will be published in the journal within 2 month.
Manuscripts (in English), together with a covering letter from the author responsible for all correspondence, should be submitted via Electronic form in Microsoft word may also be submitted through e-mails to : editorBELS@gmail.com
ONLINE SUBMISSION FORM:
Editorial board will be provide manuscript id within 3-7 day after article submission.
BEPLS follow double- blind review process. All manuscripts are reviewed by the Editorial board as well as by qualified reviewers from the concerned field [Link]
TYPE OF MANUSCRIPTS*
Original article : Not Exceed more than 8 Pages
Review Article : Not Exceed more than 15 Pages
Short Communication : Not Exceed more than 3 Pages
Research Note : Not Exceed more than 3 Pages
Case Study : Not Exceed more than 3 Pages
[Font : Cambria 10" Single Space]
PREPARATION OF MANUSCRIPTS
Manuscripts should be prepared in English using a word processor. Manuscripts should be typed in double-spaced throughout including the reference section, with wide (3 cm) margins, in each side.
Should be short, specific and informative. The title page should include the names (s) of author (s), affiliation, mailing address and contact with e-mail of corresponding author, a running short title not exceeding 40 characters. By-line should contain the place (organization) where research was conducted.
Italic Forms, Written in complete and simple sentence should not be more than 250 words. Key words (maximum 7) must be given, and these should appear just beneath the abstract.
Beginning with a new page, it should be brief and limited to the statement of the problem/ objectives and aims of the experiments with brief review of literature pertaining to the type of work.
MATERIALS AND METHODS
The Materials and Methods section should provide sufficient technical details to allow others to replicate and build on published results. New procedures should be described in detail while previously published procedures can be briefly described and appropriately cited. Sources of all important chemicals, equipment, or microbial strains should be indicated.
Statistical Methods: The variation of data should be expressed in terms of the standard error of mean (SEM) or the standard deviation (SD), along with the number of observations (n). The details of statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test.
RESULTS AND DISCUSSION
It should include important findings discussed briefly. Wherever necessary, elaborate on the tables and figures without repeating their contents. Interpret the findings in view of the results obtained in this and in past studies on this topic. State the conclusions in a few sentences at the end of the paper. However, colored photographs can be published only if the authors agree to bear the cost.
Tables should be typed on separate sheets and should bear a short descriptive title.
It should be of good quality [600 dpi JPEG format] drawn in black and white or colour on good quality tracing paper. The captions of the figures should be typed on a separate page. The figures should not exceed 18 x 15 cm size.
The photographs (JPEG format) for publication should be of high contrast on glossy paper without folds or creases. Each illustration or plate should be as a separate sheet with the name (s) of author (s) and figure number printed lightly with soft pencil on the reverse side.
EQUATIONS & UNITS
All equations should be type written by equation editor or other software. Mathematical notations should be simple and suitable for multidisciplinary audience. All data should be in metric units with single decimals. The data must be accompanied with statistical analysis. The papers not conforming to the above format will be returned without processing.
DECLARATIONS (following statements to be added just before References):
Acknowledgements of any financial support and personal assistance for the work being published must be indicated.
Conflict of Interest
All authors must declare any conflict of interest or any affiliation or involvement in any organization whether it is academic, commercial, financial, personal and professionally relevant to the work under consideration to avoid the potential for bias and accept responsibility for what is said in the manuscript.
Each author contribution should be clearly mentioned.
Kindly mention the Grant number and the funding organisation name, if any.
If the study involves an experiment on humans and animals; then the name of the authorizing body should be stated in the paper.
If the study involves an experiment on humans and animals; Manuscripts should include a statement that the informed consent was obtained for experimentation and that it conforms to the standards currently applied in the country of origin. The privacy rights of human subjects must always be observed.
Kindly mention the database or the repository name(s) along with the Accession number(s) if all datasets generated or analyzed during this study are not included in the manuscript and/or the Supplementary files.
References should be referred by a number in the text, listed according to this numbering at the end of the paper. Unpublished data should not be cited in the references. The references should comprise the following information and in the order as given in the examples below:
. Grochulski, P., Masson, L., Borisova, S., Pusztai, M.C., Schwarta, J.L., Brousseau R. & Cygler, M. (1995). Bacillus thuringiensis Cry1A (a) insecticidal toxin: Crystal structure and channel formation. J. Mol. Biol., 254(2):447-464.
Research article with DOI:
Hamed A, Nedal A, Al-Mnayyis A, et al. (2020). COVID-19 – Knowledge, Attitude and Practice among Medical and Non-Medical University Students in Jordan, J Pure Appl Microbiol. 2020;14(1):17-24. https://doi.org/10.22207/BEPLS.14.1.04
. Estruch, J., Warren, G.W., Mullins, M.A., Nye, G.J. Craig, J.A. & Joziel, H.G. (1996). Transgenic Plants: An emerging approach to pest control. In: Proceedings of National Academy of Sciences, 1995, USA, 93:5369-5395.
Book and chapters:
. Winston, J.E. (1999). Describing Species. Columbia University
Press, New York pp.518
.Stork, N. (1997). Measuring Global Biodiversity and its Decline (Eds. Reakakudla, M.L., Wilson, D.E. and Wilson, E.O.) Biodiversity II, Joseph Henry Press, Washington DC, p.41-68
Aviv H, Friedman K and Vered V. Submicron emulsions as ocular drug delivery vehicles. U.S. Patent US 5496811; 1996.
Quick dissolving tablets. http://www.biospace.com, Accessed 27 may, 2001.
ETHICS IN ANIMAL AND CLINICAL INVESTIGATION
Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee in accordance with "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) or Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that the investigation was approved and that informed consent was obtained.
ETHICAL CLEARANCE CERTIFICATE
All studies conducted on patients / volunteers/ Human biological material/animals should submit a scanned copy of Ethical Clearance Certificate.
Authors of accepted articles are supplied of printer's proofs online on their Author centre and will also receive email alerts when proofs are available. Corrections on the page proofs should be restricted to printer's errors only and no substantial additions/deletions should be made. No change in the names of the authors (by way of additions and deletions) is permissible at the proof stage. If there are valid reasons for such a change, after acceptance of a paper, the permission of the Editor-In-Chief must be sought.
ARTICLE PUBLICATION CHARGES
Publication processing fee included charges for web hosting, DOI, final editing, indexing etc. Author required to pay these processing charges after acceptance of article. Following revised processing fee is applicable to the authors:
Fee for Indian (INR)
Fee for out of India (USD)
Review article/ Research article/ short communication
The authors must ensure that before submitting the manuscript for publication, they have taken care of the following:
1. Title page should contain title, name of the author(s), their qualifications, mailing address for future correspondence, email address, phone and fax number.
2. Abstract in structured format up to 250 words.
3. Keywords contain 3-5 words.
4. References should be typed as instruction that mentioned above.
5. Tables and figures should be typed at the end of the article.
6. Copyright (covering) Letter.
7. Covering Letter
ARTICLE WITHDRAWAL POLICY
Articles can be withdrawn by the authors only for the most compelling and unavoidable reasons, after submitting a letter signed by all the authors of the article to the editorial office stating the reason for article withdrawal. Authors must not assume that their article has been withdrawn until they have received appropriate notification to this effect from the editorial office.
an author requests to withdraw the article after it has been
peer-reviewed, or after it has been typeset (but not yet published)
he/she will be charged according to the following:
For India Rs. 3500/- & for other countries USD 110/- per article (after peer-review) and Rs. 4500/- for India & USD 150/- for other countries per article (after peer-review and typesetting).
Each manuscript must be accompanied by a statement that it has been neither published nor submitted for publication, in whole or in part, either in a serial, professional journal or as a part in a book which is formally published and made available to the public. For the mutual benefit and protection of authors and publishers it is necessary that authors provide formal written consent to publisher and transfer of copyright form after acceptance of papers.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled ""___________________________________________________________________
submitted for publication in the Bulletin of Environment, Pharmacology and Life Sciences :-
1.The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2.We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge BEPLS's conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. ____________________________ ______________________________
2. ____________________________ ______________________________
3. _____________________________ ______________________________
4. _____________________________ ______________________________
5. _____________________________ ______________________________
6. _____________________________ ______________________________
7. _____________________________ ______________________________
(i) All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/country and whose whereabouts are not known, the senior author may sign on his/her behalf taking the responsibility.
(ii) No addition/deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor -in-Chief.
(iii) If the authorship is contested at any stage, the article will be either returned or will not be processed for publication till the issue is solved.